These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18598)

  • 1. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
    Yabuuchi Y; Yamashita S; Tei SS
    J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
    [No Abstract]   [Full Text] [Related]  

  • 2. Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat.
    Yamashita S; Takai M; Yabuuchi Y
    J Pharm Pharmacol; 1978 May; 30(5):273-9. PubMed ID: 26738
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of prostaglandin Bl on systemic and regional hemodynamics].
    Ismailov ShI; Flerov EV
    Biull Eksp Biol Med; 1977 Feb; 83(2):131-3. PubMed ID: 851612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and bronchomotor responses to selective beta adrenergic receptor agonists in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 May; 189(2):445-55. PubMed ID: 4151394
    [No Abstract]   [Full Text] [Related]  

  • 6. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.
    Himori N; Taira N
    Br J Pharmacol; 1977 Sep; 61(1):9-17. PubMed ID: 21014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
    Flerov EV; Ismailov ShI
    Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of high doses of pethidine and fentanyl on hemodynamics in the dog].
    Avril G; Freye E
    Cah Anesthesiol; 1984; 32(1):15-9. PubMed ID: 6529629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between pharmacological effect and chemical structure of new pyrimidine derivatives. II. Effect on various hemodynamic and biochemical parameters].
    Oledzka K
    Acta Pol Pharm; 1979; 36(2):251-8. PubMed ID: 532681
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
    Yamazaki J; Sugimoto T; Yabana H; Nagao T
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dobutamine on coronary circulation and cardiac metabolism of the dog.
    Sakanashi M; Tomomatsu E; Takeo S; Araki H; Iwasaki K; Sakamoto K; Takenaka F
    Arzneimittelforschung; 1978; 28(5):798-801. PubMed ID: 581958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coronary blood flow, myocardial contractility, and heart rate on cardiac lymph circulation in open-chest dogs. Use of a direct cannulation method for subepicardial lymph vessel.
    Saito D; Hasui M; Shiraki T; Kono H
    Arzneimittelforschung; 1997 Feb; 47(2):119-24. PubMed ID: 9079229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
    Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
    Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmural ventricular distribution of coronary blood flow during coronary beta 2-adrenergic receptor activation in dogs.
    Domenech RJ; MacLellan PR
    Circ Res; 1980 Jan; 46(1):29-36. PubMed ID: 6101266
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
    Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
    Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 20. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.